| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cd7465a66ab359165b06e35d7fab4ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2156c4beb0c5f61115e9d4163a2e893b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af8802fb2070f9b3fd174d13fcccc394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f94c2ccd49ddaaf73d1b38d8574333f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_925f7b1a8085e6bb4f5a56ba584f3df9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2007-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a76784dc68d1ab325047d1f4f733a02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c75cc0399dc34e60b19ce146f970f0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1fffc36014f67e9e84ca9967186b235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69ecbd86b0e4d4f237e07b3e87f34cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2dec69be8ca55e6ce2c74f1135c2cf0 |
| publicationDate |
2009-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008017331-A3 |
| titleOfInvention |
Peroral drug form comprising dienogest and ethinyl estradiol for contraception |
| abstract |
An oral drug form for contraception comprises as one active component 17α-cyanomethyl-17-ß-hydroxyestra-4,9-dien-3-one (dienogest) in a daily dosage of equal to or less than 2.0 mg and as other active component 17α-ethynyl estradiol (ethinyl estradiol) in a daily dosage of less than 0.03 mg together with one or more pharmaceutically acceptable carriers. The active ingredient dienogest is present in crystalline form with an average particle size of from 25 to 70 µm. The active ingredient ethinyl estradiol is introduced in micronized form or as ethanolic solution during the granulation. |
| priorityDate |
2006-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |